Investors
News
Contact

About us
Inhalers
- Inhalers
- ICOres
- ICOcap
- ICOpre
- ICOone
- ICOone Nasal
- Patents
Development services
Partner with us
Insights
- Replacing injections with inhalation
- Boost your business with an innovative inhaler partner
Investors
Search
Menu Menu

Annual Report 2017 (Only in Swedish)

February 28, 2018/in News /by Eva Norell

Nu finns Årsredovisningen inklusive revisionsberättelse för Iconovo AB tillgänglig för 2017 (Only in Swedish)
Ladda ner årsredovisning 2017

Share this entry

Share on Twitter
Share on LinkedIn
Share by Mail

https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png 0 0 Eva Norell https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png Eva Norell2018-02-28 12:44:442018-02-28 12:44:44Annual Report 2017 (Only in Swedish)

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B

POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

Home
Development services
Investors

Press releases

Annual Report 2016 (Only in Swedish) Initial Public Offering (IPO) 2018 (Only in Swedish)

Scroll to top